ストックスクリーナーアプリを入手
21.45
0.19%
-0.04
前日終値:
$21.49
開ける：
$21.36
24時間の取引高:
2.22M
Relative Volume:
2.71
時価総額：
$3.09B
収益：
$340.81M
当期純損益:
$-419.65M
株価収益率:
-19.68
EPS:
-1.09
ネットキャッシュフロー:
$-402.10M
1週間 パフォーマンス:
-6.62%
1か月 パフォーマンス:
-12.16%
6か月 パフォーマンス:
+0.23%
1年 パフォーマンス:
+1.32%
1日の値動き範囲:
$21.00
$22.21
1週間の範囲:
$20.76
$24.15
52週間の値動き範囲:
$14.56
$33.33
Denali Therapeutics Inc Stock (DNLI) Company Profile
名前
Denali Therapeutics Inc
セクター
電話
(650) 866-8548
住所
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO
DNLI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DNLI
Denali Therapeutics Inc
|
21.45 | 3.09B | 340.81M | -419.65M | -402.10M | -2.85 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Denali Therapeutics Inc Stock (DNLI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-16 | アップグレード | Stifel | Hold → Buy |
| 2024-10-10 | 再開されました | Raymond James | Mkt Perform |
| 2024-10-07 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2023-12-13 | 開始されました | Citigroup | Buy |
| 2023-11-20 | 再開されました | JP Morgan | Overweight |
| 2023-10-24 | 再開されました | Cantor Fitzgerald | Overweight |
| 2023-09-06 | 開始されました | B. Riley Securities | Buy |
| 2023-01-30 | 開始されました | SVB Securities | Outperform |
| 2022-12-05 | 開始されました | Cowen | Outperform |
| 2022-11-02 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-11-02 | 開始されました | BofA Securities | Buy |
| 2022-06-23 | 開始されました | Berenberg | Buy |
| 2021-12-10 | 再開されました | Raymond James | Mkt Perform |
| 2021-09-21 | 開始されました | Oppenheimer | Outperform |
| 2021-09-01 | 開始されました | SMBC Nikko | Outperform |
| 2021-05-18 | 開始されました | UBS | Buy |
| 2021-02-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2021-02-10 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2020-11-11 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-10-16 | ダウングレード | BTIG Research | Buy → Neutral |
| 2020-09-14 | 再開されました | JP Morgan | Overweight |
| 2020-08-20 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-13 | アップグレード | Evercore ISI | In-line → Outperform |
| 2020-02-28 | アップグレード | Wedbush | Neutral → Outperform |
| 2020-02-24 | 開始されました | Jefferies | Buy |
| 2020-02-19 | 開始されました | Stifel | Hold |
| 2020-01-27 | アップグレード | Goldman | Neutral → Buy |
| 2019-09-26 | 開始されました | Wedbush | Neutral |
| 2019-09-13 | 開始されました | Nomura | Buy |
| 2019-08-09 | 開始されました | BTIG Research | Buy |
| 2019-06-26 | 開始されました | H.C. Wainwright | Buy |
| 2018-11-15 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-11-12 | 開始されました | Janney | Buy |
| 2018-03-12 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2018-01-02 | 開始されました | Evercore ISI | Outperform |
| 2018-01-02 | 開始されました | Goldman | Neutral |
| 2018-01-02 | 開始されました | JP Morgan | Overweight |
| 2018-01-02 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Denali Therapeutics Inc (DNLI) 最新ニュース
Geode Capital Management LLC Sells 27,061 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Denali Therapeutics Inc. (NASDAQ:DNLI) Shares Purchased by Barclays PLC - MarketBeat
Denali Therapeutics upgraded to Buy from Hold at Stifel - Yahoo Finance
Y Intercept Hong Kong Ltd Sells 25,369 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Denali Therapeutics (NASDAQ:DNLI) Shares Gap UpTime to Buy? - MarketBeat
Denali Therapeutics (NASDAQ:DNLI) Upgraded to Buy at Stifel Nicolaus - MarketBeat
Denali Therapeutics Inc. (NASDAQ:DNLI) Receives $38.90 Average PT from Brokerages - MarketBeat
Nomura Asset Management Co. Ltd. Buys Shares of 65,033 Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
State Street Corp Sells 182,779 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
When (DNLI) Moves Investors should Listen - Stock Traders Daily
We're Hopeful That Denali Therapeutics (NASDAQ:DNLI) Will Use Its Cash Wisely - Simply Wall St
Point72 Asset Management L.P. Trims Stock Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Wellington Management Group LLP Has $312.49 Million Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Denali Starts Dosing in Phase II Parkinson's Disease Study - MSN
Why Is Denali Therapeutics (DNLI) Down 21.2% Since Last Earnings Report? - Yahoo Finance
Temasek Holdings Private Ltd Lowers Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Holocene Advisors LP Has $2.84 Million Stake in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
The Manufacturers Life Insurance Company Has $6.03 Million Stock Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Charles Schwab Investment Management Inc. Trims Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Denali Therapeutics Announces First Participant Dosed in - GlobeNewswire
Denali Therapeutics Launches Key Phase 2a Trial for Breakthrough Parkinson's Treatment - StockTitan
26,900 Shares in Denali Therapeutics Inc. (NASDAQ:DNLI) Purchased by Erste Asset Management GmbH - MarketBeat
Denali Therapeutics Inc. (NASDAQ:DNLI) Position Boosted by Cinctive Capital Management LP - MarketBeat
Fmr LLC Purchases 7,596,508 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Stock Position in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Wasatch Advisors LP Reduces Stock Position in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Denali Therapeutics Inc. (NASDAQ:DNLI) Shares Bought by Fred Alger Management LLC - MarketBeat
Denali Therapeutics Getting Closer To Key Technical Measure - MSN
Algert Global LLC Has $1.42 Million Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
29,543 Shares in Denali Therapeutics Inc. (NASDAQ:DNLI) Purchased by Intech Investment Management LLC - MarketBeat
Fisher Asset Management LLC Buys 69,223 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
PTC halts development of ALS drug after trial miss - The Pharma Letter
Victory Capital Management Inc. Has $1.16 Million Position in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Objective long/short (DNLI) Report - Stock Traders Daily
Denali Therapeutics Inc. (NASDAQ:DNLI) Receives $38.90 Consensus PT from Analysts - MarketBeat
Denali Q3 Earnings Miss Estimates, Pipeline Progress Encouraging - MSN
Denali Therapeutics updates bylaws, aligns with SEC rules - Investing.com India
Denali Therapeutics updates bylaws, aligns with SEC rules By Investing.com - Investing.com UK
Denali Therapeutics (NASDAQ:DNLI) Trading Down 8.3%Here's What Happened - MarketBeat
Denali Has A Neurodegenerative Edge Despite Market Skepticism (NASDAQ:DNLI) - Seeking Alpha
Los Angeles Capital Management LLC Trims Stock Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
State of New Jersey Common Pension Fund D Sells 25,613 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Capital Research Global Investors Expands Stake in Denali Therap - GuruFocus.com
NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears - GlobeNewswire
FMR LLC Expands Stake in Denali Therapeutics Inc - GuruFocus.com
BofA raises Denali Therapeutics target to $34 on BLA plans By Investing.com - Investing.com Canada
Denali Therapeutics executive sells shares worth $465,286 - Investing.com India
Denali Therapeutics executive sells shares worth $465,286 By Investing.com - Investing.com Canada
Baillie Gifford & Co. Sells 417,709 Shares of Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Principal Financial Group Inc. Increases Stock Position in Denali Therapeutics Inc. (NASDAQ:DNLI) - MarketBeat
Denali Therapeutics Inc (DNLI) 財務データ
収益
当期純利益
現金流量
EPS
Denali Therapeutics Inc (DNLI) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Schuth Alexander O. | COFO and Secretary |
Nov 22 '24 |
Option Exercise |
0.68 |
20,516 |
13,951 |
198,582 |
| Schenkein David P | Director |
Nov 11 '24 |
Option Exercise |
18.00 |
47,165 |
848,970 |
68,661 |
| Schenkein David P | Director |
Nov 11 '24 |
Sale |
32.51 |
59,441 |
1,932,665 |
9,220 |
| Schuth Alexander O. | COFO and Secretary |
Nov 07 '24 |
Option Exercise |
5.28 |
15,558 |
82,146 |
193,624 |
| Schuth Alexander O. | COFO and Secretary |
Nov 07 '24 |
Sale |
29.91 |
15,558 |
465,286 |
178,066 |
| SATO VICKI L | Director |
Nov 07 '24 |
Sale |
30.00 |
1,020 |
30,600 |
111,056 |
2.88%
2.65%
大文字化:
|
ボリューム (24 時間):